Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo

[1]  D. Takai,et al.  Genome structure‐based screening identified epigenetically silenced microRNA associated with invasiveness in non‐small‐cell lung cancer , 2012, International journal of cancer.

[2]  J. Soh,et al.  Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer. , 2012, Lung cancer.

[3]  Yan Wang,et al.  CpG island methylation status of miRNAs in esophageal squamous cell carcinoma , 2012, International journal of cancer.

[4]  Jin Cao,et al.  Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1. , 2012, Gynecologic oncology.

[5]  Wei-Guo Zhu,et al.  5‐Aza‐2'‐deoxycytidine reactivates gene expression via degradation of pRb pocket proteins , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  W. Guo,et al.  MicroRNA‐9 up‐regulates E‐cadherin through inhibition of NF‐κB1–Snail1 pathway in melanoma , 2012, The Journal of pathology.

[7]  W. Guo,et al.  Hypoxia‐inducible MicroRNA‐210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma , 2011, Hepatology.

[8]  Sung-Chou Li,et al.  Epigenetic regulation of miR‐34b and miR‐129 expression in gastric cancer , 2011, International journal of cancer.

[9]  L. Chung,et al.  Epigenetic inactivation of the hsa-miR-203 in haematological malignancies , 2011, Journal of cellular and molecular medicine.

[10]  J. Inazawa,et al.  miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer. , 2011, Cancer research.

[11]  Wen-Ching Chan,et al.  Aberrant hypermethylation of miR-9 genes in gastric cancer , 2011, Epigenetics.

[12]  D. Khaitan,et al.  Epigenetic Regulation of MicroRNA Genes and the Role of miR-34b in Cell Invasion and Motility in Human Melanoma , 2011, PloS one.

[13]  W. Cho.  Epigenetic alteration of microRNAs in feces of colorectal cancer and its clinical significance , 2011, Expert review of molecular diagnostics.

[14]  M. Esteller,et al.  Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis , 2011, Oncogene.

[15]  Shaojie Zhang,et al.  Epigenetic regulation of microRNA‐375 and its role in melanoma development in humans , 2011, FEBS letters.

[16]  J. Soh,et al.  Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma , 2011, Clinical Cancer Research.

[17]  C. Godfraind,et al.  MicroRNA and Target Protein Patterns Reveal Physiopathological Features of Glioma Subtypes , 2011, PloS one.

[18]  H. Rehrauer,et al.  Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis. , 2011, Cancer research.

[19]  Jiansheng Li,et al.  Epigenetic Silencing of MicroRNA-375 Regulates PDK1 Expression in Esophageal Cancer , 2011, Digestive Diseases and Sciences.

[20]  S. Leng,et al.  EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. , 2011, Cancer research.

[21]  R. Stone,et al.  MicroRNA‐137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck , 2011, Cancer.

[22]  D. Norris,et al.  MicroRNA-137 Targets Carboxyl-terminal Binding Protein 1 in Melanoma Cell Lines , 2011, International journal of biological sciences.

[23]  Q. Fan,et al.  miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42 , 2011, Digestive Diseases and Sciences.

[24]  M. Toyota,et al.  Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. , 2010, Carcinogenesis.

[25]  C. Croce,et al.  Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. , 2010, Cancer research.

[26]  G. Tsujimoto,et al.  MicroRNA-210 Regulates Cancer Cell Proliferation through Targeting Fibroblast Growth Factor Receptor-like 1 (FGFRL1)* , 2010, The Journal of Biological Chemistry.

[27]  J. Gu,et al.  Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma , 2010, Oncogene.

[28]  H. Oja,et al.  miR‐193b is an epigenetically regulated putative tumor suppressor in prostate cancer , 2010, International journal of cancer.

[29]  C. Boland,et al.  Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. , 2010, Cancer research.

[30]  I. Bozzoni,et al.  A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation , 2010, Nucleic acids research.

[31]  Seung‐Mo Hong,et al.  Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. , 2010, Cancer research.

[32]  R. Agami,et al.  Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer , 2010, Molecular Cancer.

[33]  Shu Shimada,et al.  Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis. , 2010, Carcinogenesis.

[34]  P. Sonneveld,et al.  Micro-RNA-15a and micro-RNA-16 expression and chromosome 13 deletions in multiple myeloma. , 2010, Leukemia research.

[35]  Scott M Langevin,et al.  MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index. , 2010, Carcinogenesis.

[36]  Shinji Tanaka,et al.  miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. , 2010, Carcinogenesis.

[37]  Hua Su,et al.  MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. , 2010, Cell stem cell.

[38]  M. Seto,et al.  MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. , 2010, Cancer research.

[39]  D. Fan,et al.  MiR-218 Inhibits Invasion and Metastasis of Gastric Cancer by Targeting the Robo1 Receptor , 2010, PLoS genetics.

[40]  Eugene Berezikov,et al.  Expression patterns of intronic microRNAs in Caenorhabditis elegans , 2010, Silence.

[41]  Xabier Agirre,et al.  Epigenetic regulation of microRNA expression in colorectal cancer , 2009, International journal of cancer.

[42]  Zhihui Feng,et al.  A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. , 2009, Gynecologic oncology.

[43]  G. Calin,et al.  miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy , 2009, Clinical Cancer Research.

[44]  G. Shukla,et al.  Intrinsic expression of host genes and intronic miRNAs in prostate carcinoma cells , 2009, Cancer Cell International.

[45]  P. Andrew Futreal,et al.  Amplification and Overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in Medulloblastoma , 2009, PloS one.

[46]  Vassilis Georgoulias,et al.  Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. , 2008, Clinical chemistry.

[47]  M. F. Shannon,et al.  A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. , 2008, Cancer research.

[48]  Raquel Díaz,et al.  Deregulated expression of miR‐106a predicts survival in human colon cancer patients , 2008, Genes, chromosomes & cancer.

[49]  Carola Berking,et al.  Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer , 2008, Cell cycle.

[50]  D. Deng,et al.  Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history , 2008, BMC Microbiology.

[51]  J. Inazawa,et al.  Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. , 2008, Cancer research.

[52]  R. Vyzula,et al.  Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer , 2008, Oncology.

[53]  U. Lehmann,et al.  Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancer , 2008, The Journal of pathology.

[54]  D. Katsaros,et al.  Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. , 2007, Cancer research.

[55]  Wei Wang,et al.  MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. , 2007, Cancer research.

[56]  J. Ji,et al.  Methylation of CpG islands of p16 associated with progression of primary gastric carcinomas , 2006, Laboratory Investigation.

[57]  H Tunstall-Pedoe,et al.  Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. , 2005, JAMA.

[58]  Oliver H. Tam,et al.  Characterization of Dicer-deficient murine embryonic stem cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[59]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[60]  M. J. Conroy,et al.  Use of fluorescent DNA-intercalating dyes in the analysis of DNA via ion-pair reversed-phase denaturing high-performance liquid chromatography. , 2002, Analytical biochemistry.

[61]  S. Powell,et al.  Simultaneous detection of CpG methylation and single nucleotide polymorphism by denaturing high performance liquid chromatography. , 2002, Nucleic acids research.

[62]  D. Deng,et al.  Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers. , 2010, Advances in genetics.

[63]  A W Langerak,et al.  17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation , 2009, Leukemia.

[64]  D. Birnbaum,et al.  BMC Cancer , 2003 .

[65]  P. Laird,et al.  Combined bisulfite restriction analysis (COBRA). , 2002, Methods in molecular biology.